The following Appendix 4D and Half-Year Report has been lodged with ASX.
Read Appendix 4D and Half-Year Report.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance